Cargando…
Current treatment options for newly diagnosed metastatic hormone-sensitive prostate cancer—a narrative review
Prostate cancer continues to be one of the most commonly diagnosed cancers in men globally and a leading cause of male cancer deaths. The landscape of metastatic hormone-sensitive prostate cancer has significantly changed over the past decade. For many years, androgen deprivation therapy alone throu...
Autores principales: | Ong, Sean, O’Brien, Jonathan, Medhurst, Elizabeth, Lawrentschuk, Nathan, Murphy, Declan, Azad, Arun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575582/ https://www.ncbi.nlm.nih.gov/pubmed/34804835 http://dx.doi.org/10.21037/tau-20-1118 |
Ejemplares similares
-
Finding the optimal treatment sequence in metastatic castration-resistant prostate cancer—a narrative review
por: Maurice Dror, Corinne, et al.
Publicado: (2021) -
Narrative review: prostate-specific membrane antigen-radioligand therapy in metastatic castration-resistant prostate cancer
por: Lunger, Lukas, et al.
Publicado: (2021) -
Narrative review of challenges in the management of advanced neuroendocrine prostate cancer
por: Okasho, Kosuke, et al.
Publicado: (2021) -
A marrow-minded look at immune checkpoint blockade resistance in metastatic castration resistant prostate cancer
por: Fonseca, Nicolette M., et al.
Publicado: (2021) -
Narrative review of developing new biomarkers for decision making in advanced testis cancer
por: Nappi, Lucia, et al.
Publicado: (2021)